Results 221 to 230 of about 110,638 (255)

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

Lancet, The, 2008
Christopher G Wood, Louis Lacombe
exaly  

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

New England Journal of Medicine, 2018
Arnaud Méjean, Alain Ravaud, Antoine Thiery-vuillemin   +2 more
exaly  

Nephrectomy and Partial Nephrectomy

2013
openaire   +1 more source

Cytoreductive nephrectomy in metastatic renal cancer — less is more

Nature Reviews Clinical Oncology, 2018
Axel Bex
exaly  

NEPHRECTOMY

The American Journal of the Medical Sciences, 1885
openaire   +2 more sources

Towards rational post-nephrectomy follow-up guidelines in RCC

Nature Reviews Clinical Oncology, 2015
Bernard Escudier
exaly  

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

Lancet, The, 2001
exaly  

Partial Nephrectomy Versus Radical Nephrectomy in Patients With Small Renal Tumors—Is There a Difference in Mortality and Cardiovascular Outcomes?

Journal of Urology, 2009
William C Huang, Andrew S Levey, Paul Russo   +2 more
exaly  

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

Lancet, The, 2004
exaly  

[Partial nephrectomy].

Revista argentina de urologia, 1998
openaire   +2 more sources